You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The lab's involvement will increase opportunities for cancer patients in these rural states to enroll in the trial and access molecularly informed treatments.
Jackson Laboratory researchers will lead an interdisciplinary team of experts to study the employee health benefits of workplace genetic testing.
The sequence-based analysis suggests oncogene-containing circular, extrachromosomal sequences occur in most cancer types and may correspond with poorer patient outcomes.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
The Economist reports on the development of mouse models to study COVID-19.
In PLOS this week: transcriptomics-based strategy to study Alzheimer's disease heterogeneity, insecticide resistance diversity and evolution, and more.
Fresh off a new investment round, the British firm seeks to help research labs and biopharma companies manage population-level genomics research.
The alliance comes a few months after Shriners Hospitals established a new genomics institute in Tampa, Florida in partnership with Genome Medical.
The researchers are aiming to provide new insights as to which cancer patients will respond best to immunotherapy based on their genetic backgrounds.
Researchers at the Jackson Laboratory have tested an early version of the GenapSys sequencer and found it to have a very low mismatch error rate.
SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.
The New York Times reports that a new viral variant of concern has been identified in New York City.
In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.
According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.